These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33880030)

  • 41. Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis.
    Van Doornum S; McColl G; Wicks IP
    Rheumatology (Oxford); 2005 Nov; 44(11):1428-32. PubMed ID: 16076882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TNF-alpha antagonism and cancer risk in rheumatoid arthritis: is continued vigilance warranted?
    Park HJ; Ranganathan P
    Discov Med; 2012 Mar; 13(70):229-34. PubMed ID: 22463799
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathogenesis of ischaemic and non-ischaemic heart diseases in rheumatoid arthritis.
    Błyszczuk P; Szekanecz Z
    RMD Open; 2020 Jan; 6(1):. PubMed ID: 31958278
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent progress and perspective in JAK inhibitors for rheumatoid arthritis: from bench to bedside.
    Tanaka Y
    J Biochem; 2015 Sep; 158(3):173-9. PubMed ID: 26152731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of apoptosis and inflammatory responses by insulin-like growth factor binding protein 3 in fibroblast-like synoviocytes and experimental animal models of rheumatoid arthritis.
    Lee HS; Woo SJ; Koh HW; Ka SO; Zhou L; Jang KY; Lim HS; Kim HO; Lee SI; Park BH
    Arthritis Rheumatol; 2014 Apr; 66(4):863-73. PubMed ID: 24757139
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of inflammation in atherosclerosis associated with rheumatoid arthritis.
    Libby P
    Am J Med; 2008 Oct; 121(10 Suppl 1):S21-31. PubMed ID: 18926166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [THE EFFECT OF BIOLOGIC THERAPY ON THE LIPID PROFILE OF RHEUMATOID ARTHRITIS (RA), PSORIATIC ARTHRITIS (PSA) AND ANKYLOSING SPONDYLITIS (AS) PATIENTS].
    Hassan S; Feld J; Cohen S; Zisman D
    Harefuah; 2017 Jul; 156(7):446-450. PubMed ID: 28786273
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stress activation of cellular markers of inflammation in rheumatoid arthritis: protective effects of tumor necrosis factor alpha antagonists.
    Motivala SJ; Khanna D; FitzGerald J; Irwin MR
    Arthritis Rheum; 2008 Feb; 58(2):376-83. PubMed ID: 18240230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methotrexate chronotherapy is effective against rheumatoid arthritis.
    To H; Yoshimatsu H; Tomonari M; Ida H; Tsurumoto T; Tsuji Y; Sonemoto E; Shimasaki N; Koyanagi S; Sasaki H; Ieiri I; Higuchi S; Kawakami A; Ueki Y; Eguchi K
    Chronobiol Int; 2011 Apr; 28(3):267-74. PubMed ID: 21452922
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets.
    Liu W; Zhang Y; Zhu W; Ma C; Ruan J; Long H; Wang Y
    Front Immunol; 2018; 9():2228. PubMed ID: 30319663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.
    Sfikakis PP; Bournia VK; Sidiropoulos P; Boumpas DT; Drosos AA; Kitas GD; Konstantonis G; Liossis SN; Manoussakis MN; Sakkas L; Tektonidou M; Tzioufas AG; Vlachoyiannopoulos PG; Kani C; Paterakis P; Litsa P; Vassilopoulos D
    Clin Exp Rheumatol; 2017; 35(4):579-585. PubMed ID: 28281458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients.
    Ruscitti P; Cipriani P; Di Benedetto P; Liakouli V; Berardicurti O; Carubbi F; Ciccia F; Alvaro S; Triolo G; Giacomelli R
    Clin Exp Immunol; 2015 Oct; 182(1):35-44. PubMed ID: 26095630
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phosphorylated Platelet-Derived Growth Factor Receptor-Positive Cells With Anti-apoptotic Properties Accumulate in the Synovium of Patients With Rheumatoid Arthritis.
    Matsumura T; Saito Y; Suzuki T; Teramoto A; Ozasa Y; Yamashita T; Fujimiya M; Saito-Chikenji T
    Front Immunol; 2019; 10():241. PubMed ID: 30828336
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cardiovascular comorbidities in rheumatoid arthritis].
    Krüger K; Nüßlein H
    Z Rheumatol; 2019 Apr; 78(3):221-227. PubMed ID: 30656399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum cytokine and periodontal profiles in relation to disease activity of rheumatoid arthritis in Japanese adults.
    Kobayashi T; Murasawa A; Komatsu Y; Yokoyama T; Ishida K; Abe A; Yamamoto K; Yoshie H
    J Periodontol; 2010 May; 81(5):650-7. PubMed ID: 20429644
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept.
    Fleischmann R; Iqbal I; Nandeshwar P; Quiceno A
    Drug Saf; 2002; 25(3):173-97. PubMed ID: 11945114
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Level of N-terminal fragment of brain natriuretic peptide progenitor and atherosclerotic damage of brachocephalic arteries in patients with rheumatoid arthritis with inefficiency and/or injurability of basic anti - inflammatory treatment].
    Gerasimova EV; Popkova TV; Martynova AV; Markelova EI; Novikova DS; Kirillova IG
    Ter Arkh; 2019 May; 91(5):34-39. PubMed ID: 32598674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blockade of bone morphogenetic protein signaling potentiates the pro-inflammatory phenotype induced by interleukin-17 and tumor necrosis factor-α combination in rheumatoid synoviocytes.
    Varas A; Valencia J; Lavocat F; Martínez VG; Thiam NN; Hidalgo L; Fernández-Sevilla LM; Sacedón R; Vicente A; Miossec P
    Arthritis Res Ther; 2015 Jul; 17(1):192. PubMed ID: 26215036
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biologic rheumatoid arthritis therapies: do we need more comparative effectiveness data?
    Levesque MC
    BioDrugs; 2012 Apr; 26(2):65-70. PubMed ID: 22385403
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumour necrosis factor-alpha blockade: a new era for effective management of rheumatoid arthritis.
    Hamilton K; Clair EW
    Expert Opin Pharmacother; 2000 Jul; 1(5):1041-52. PubMed ID: 11249494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.